Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
44,768,531
-
Shares change
-
-2,776,712
-
Total reported value, excl. options
-
$602,208,907
-
Value change
-
-$42,998,885
-
Put/Call ratio
-
100%
-
Number of buys
-
125
-
Number of sells
-
77
-
Price
-
$13.44
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2015
As of 31 Dec 2015 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,768,531 shares of stock of the company.
Largest 10 holders included BlackRock Fund Advisors, Ranger Investment Management, L.P., GLENMEDE TRUST CO NA, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Invesco Ltd., Apex Capital Management, STATE STREET CORP, KORNITZER CAPITAL MANAGEMENT INC /KS, and DIMENSIONAL FUND ADVISORS LP.
This table shows 239 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.